Results 191 to 200 of about 83,214 (263)

New and emerging pharmacologic treatments for MDD. [PDF]

Front Psychiatry
Uyar A, Gonul AS.
europepmc   +1 more source

Cancer Pain Is Not One-Size-Fits-All: Evolving from Tradition to Precision. [PDF]

Clin Pract
Shapoo N, Rehman A, Izaguirre-Rojas C, Gotlieb V, Boma N.   +4 more
europepmc   +1 more source

Renal Implications of Kappa Opioid Receptor Signaling in Sprague-Dawley Rats. [PDF]

Function (Oxf)
Didik S, Golosova D, Zietara A, Bohovyk R, Ahrari A, Levchenko V, Kravtsova O, Taneja K, Khedr S, Semenikhina M, Palygin O, Staruschenko A.   +11 more
europepmc   +1 more source

Seeing the bigger picture: endogenous opioids mediate attentional broadening after reward receipt. [PDF]

Psychol Med
van Steenbergen H, Gable P, Fagan H, Molteni L, Midveris A, Huneke N.   +5 more
europepmc   +1 more source

A New Trick of Old Dogs: Can Kappa Opioid Receptor Antagonist Properties of Antidepressants Assist in Treating Treatment-Resistant Depression (TRD)? [PDF]

Pharmaceuticals (Basel)
Schreiber S, Keidan L, Pick CG.
europepmc   +1 more source

Sex-specific genetics underlie increased chronic pain risk in women: decoding the genetic architecture of chronic pain. Comment on Br J Anaesth 2025; 135: 401-5. [PDF]

Br J Anaesth
Zeng J, Zhou Z.
europepmc   +1 more source

Opioid System Antagonism Alters Vascular Proteome and Collagen Deposition in ApoE^-/- Mice. [PDF]

Cells
Jaskuła K, Nawrocka A, Poznański P, Stachowicz A, Łazarczyk M, Sacharczuk M, Skiba DS.   +6 more
europepmc   +1 more source

Effects of Ethanol and Opioid Receptor Antagonists Naltrexone and LY2444296 on the Organization of Cholesterol- and Sphingomyelin-Enriched Plasma Membrane Domains. [PDF]

ACS Chem Neurosci
Oasa S, Mak WH, Maddox AL, Lima C, Saftics A, Terenius L, Jovanović-Talisman T, Vukojević V.   +7 more
europepmc   +1 more source

Pharmacology of newly identified nitazene variants reveals structural determinants of affinity, potency, selectivity for mu opioid receptors. [PDF]

Neuropharmacology
Kozell LB, Eshleman AJ, Wolfrum KM, Swanson TL, Schutzer KA, Schutzer WE, Abbas AI.   +6 more
europepmc   +1 more source

Targeting the kappa opioid receptor for analgesia and antitumour effects. [PDF]

Br J Anaesth
Lambert DG, Mincer JS.
europepmc   +1 more source